under the radar bio stock

This one seems to be a sleeper, they have a great product and coming into FDA decision. the product is a new type of syringe that extract ddye and powerful anibiotics that once pumped in and hit target is sucked out of the body before it hits vital organs...saves crap flowwing around your system and ghas been a big hit in some hospitals...Simple products, a simple approval process (CE mark already obtained & FDA approval relative to drugs is short and straightforward), simple endpoints,, and addressable markets, for which there is no immediate competition. I expect this to start gaining some traction especially when they get FDA which i believe could be any time now...great mkt cap